Single-cell transcriptomic analysis identifies systemic immunosuppressive myeloid cells and local monocytes/macrophages as key regulators in polytrauma-induced immune dysregulation

Abstract

Polytrauma with significant bone and volumetric muscle loss presents substantial clinical challenges. Although immune responses significantly influence fracture healing post-polytrauma, the cellular and molecular underpinnings of polytrauma-induced immune dysregulation require further investigation. While previous studies examined either injury site tissue or systemic tissue (peripheral blood), our study uniquely investigated both systemic and local immune cells at the same time to better understand polytrauma-induced immune dysregulation and associated impaired bone healing. Using single-cell RNA sequencing (scRNA-seq) in a rat polytrauma model, we analyzed blood, bone marrow, and the local defect soft tissue to identify potential cellular and molecular targets involved in immune dysregulation. We identified a trauma-associated immunosuppressive myeloid (TIM) cell population that drives systemic immune dysregulation, immunosuppression, and potentially impaired bone healing. We found CD1d as a global marker for TIM cells in polytrauma. In the local defect tissue, we observed Spp1⁺ monocytes/macrophages mediating inflammatory, fibrotic, and impaired adaptive immune responses. Finally, our findings highlighted increased signaling via Anxa1-Fpr2 and Spp1-Cd44 axes. This comprehensive analysis enhances our understanding of immune dysregulation-mediated nonunion following traumatic injury and provides biomarkers that could function as treatment targets.

References

[1] ThompsonKB, KrispinskyLT, StarkRJ. Late immune consequences of combat trauma: a review of trauma-related immune dysfunction and potential therapies. Mil. Med. Res., 2019, 611

[2] MukhametovU, et al.. Immunologic response in patients with polytrauma. Noncoding RNA Res., 2023, 8: 8-17.

[3] Huber-LangM, LambrisJD, WardPA. Innate immune responses to trauma. Nat. Immunol., 2018, 19: 327-341.

[4] RuehleMA, et al.. Effects of BMP‐2 dose and delivery of microvascular fragments on healing of bone defects with concomitant volumetric muscle loss. J. Orthop. Res., 2019, 37: 553-561.

[5] VantucciCE, et al.. Systemic immune modulation alters local bone regeneration in a delayed treatment composite model of non-union extremity trauma. Front. Surg., 2022, 9934773.

[6] VantucciCE, et al.. BMP-2 delivery strategy modulates local bone regeneration and systemic immune responses to complex extremity trauma. Biomater. Sci., 2021, 9: 1668-1682.

[7] ChengA, et al.. Early systemic immune biomarkers predict bone regeneration after trauma. Proc. Natl. Acad. Sci., 2021, 118. e2017889118

[8] VantucciCE, et al.. Development of systemic immune dysregulation in a rat trauma model of biomaterial-associated infection. Biomaterials, 2021, 264120405.

[9] VantucciCE, RoyK, GuldbergRE. Immunomodulatory strategies for immune dysregulation following severe musculoskeletal trauma. J. Immunol. Regen. Med., 2018, 2: 21-35

[10] EvansAR, et al.. The local and systemic effects of immune function on fracture healing. OTA Int., 2024, 7e328.

[11] Saiz, A. M. et al. Polytrauma impairs fracture healing accompanied by increased persistence of innate inflammatory stimuli and reduced adaptive response. J. Orthopaedic Res. 43, 603–616 (2024).

[12] BurganJ, RahmatiM, LeeM, SaizAM. Innate immune response to bone fracture healing. Bone, 2025, 190117327.

[13] LoiF, et al.. Inflammation, fracture and bone repair. Bone, 2016, 86: 119-130.

[14] HachemiY, et al.. Multimodal analyses of immune cells during bone repair identify macrophages as a therapeutic target in musculoskeletal trauma. Bone Res, 2024, 1256.

[15] Chen, T. et al. A road map from single-cell transcriptome to patient classification for the immune response to trauma. JCI Insight, 6, e145108 (2021).

[16] Grieshaber-BouyerR, et al.. The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments. Nat. Commun., 2021, 12. 2856

[17] WangT, et al.. Engineering immunomodulatory and osteoinductive implant surfaces via mussel adhesion-mediated ion coordination and molecular clicking. Nat. Commun., 2022, 13. 160

[18] WongKL, et al.. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood, 2011, 118: e16-e31.

[19] ParkJH, LeeNK, LeeSY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol. Cells, 2017, 40: 706-713.

[20] TrianaS, et al.. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states. Nat. Immunol., 2021, 22: 1577-1589.

[21] De MicheliAJ, SpectorJA, ElementoO, CosgroveBD. A reference single-cell transcriptomic atlas of human skeletal muscle tissue reveals bifurcated muscle stem cell populations. Skelet. Muscle, 2020, 10. 19

[22] RubensteinAB, et al.. Single-cell transcriptional profiles in human skeletal muscle. Sci. Rep., 2020, 10. 229

[23] VegliaF, SansevieroE, GabrilovichDI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol., 2021, 21: 485-498.

[24] BrazaMS, et al.. Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance. Am. J. Transplant., 2018, 18: 1247-1255.

[25] Ridnour, L. A. et al. Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients. Preprint at https://doi.org/10.1101/2023.12.21.572867 (2023).

[26] GavinsFNE, HickeyMJ. Annexin A1 and the regulation of innate and adaptive immunity. Front. Immunol., 2012, 3354.

[27] Jamee, M. & Rezaei, N. Autoinflammatory disorders. In: Translational autoimmunity 389–421. https://doi.org/10.1016/B978-0-12-824466-1.00007-8 (Elsevier, 2022).

[28] PetersVA, JoestingJJ, FreundGG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav. Immun., 2013, 32: 1-8.

[29] SenchenkovaEY, et al.. Novel role for the AnxA1-Fpr2/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation. Circulation, 2019, 140: 319-335.

[30] DimitrovD, et al.. LIANA⁺ provides an all-in-one framework for cell–cell communication inference. Nat. Cell Biol., 2024, 26: 1613-1622.

[31] LiE, CheungHC, MaS. CTHRC1⁺ fibroblasts and SPP1⁺ macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma. Sci. Rep., 2024, 14. 17412

[32] LiZ, ZhaoH, WangJ. Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front. Cardiovasc. Med., 2021, 8650278.

[33] Gonzalez-MenendezP, SainzRM, EvelsonP. Editorial: oxidative metabolism in inflammation. Front. Immunol., 2024, 151507700.

[34] AraújoTG, et al.. Annexin A1 as a regulator of immune response in cancer. Cells, 2021, 102245.

[35] ZhengY, et al.. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cell Mol. Immunol., 2023, 21: 47-59.

[36] FujitaY, et al.. Mitigation of acute lung injury by human bronchial epithelial cell-derived extracellular vesicles via ANXA1-mediated FPR signaling. Commun. Biol., 2024, 7514.

[37] BaiF, et al.. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer. J. Immunother. Cancer, 2020, 8e000169.

[38] Al-AliHN, et al.. A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene, 2024, 43: 608-614.

[39] AnB, et al.. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation. Biochem. Biophys. Res. Commun., 2018, 495: 519-525.

[40] OleinikaK, et al.. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells. Nat. Commun., 2018, 9. 684

[41] OgleME, SegarCE, SridharS, BotchweyEA. Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design. Exp. Biol. Med., 2016, 241: 1084-1097.

[42] LundSA, GiachelliCM, ScatenaM. The role of osteopontin in inflammatory processes. J. Cell Commun. Signal, 2009, 3: 311-322.

[43] HansakonA, PngCW, ZhangY, AngkasekwinaiP. Macrophage-derived osteopontin influences the amplification of Cryptococcus neoformans –promoting type 2 immune response. J. Immunol., 2021, 207: 2107-2117.

[44] HoeftK, et al.. Platelet-instructed SPP1⁺ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner. Cell Rep., 2023, 42. 112131

[45] Vegting, Y. et al. Infiltrative classical monocyte-derived and SPP1 lipid-associated macrophages mediate inflammation and fibrosis in ANCA-associated glomerulonephritis. Nephrol Dial Transplant.https://doi.org/10.1093/ndt/gfae292 (2024).

[46] WangL, et al.. Periosteal mesenchymal progenitor dysfunction and extraskeletally-derived fibrosis contribute to atrophic fracture nonunion. J. Bone Miner. Res., 2019, 34: 520-532.

[47] LiG, et al.. PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis. Heliyon, 2025, 11. e41628

[48] TongW, et al.. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment. J. Transl. Med., 2024, 22. 840

[49] HeH, et al.. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discov., 2023, 960.

[50] Flevas, D. A., Papageorgiou, M. G., Drakopoulos, P. & Lambrou, G. I. The role of immune system cells in fracture healing: review of the literature and current concepts. Cureus,https://doi.org/10.7759/cureus.14703 (2021).

[51] YangN, LiuY. The role of the immune microenvironment in bone regeneration. Int. J. Med. Sci., 2021, 18: 3697-3707.

[52] WolockSL, LopezR, KleinAM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst., 2019, 8: 281-291.e9.

[53] HaoY, et al.. Integrated analysis of multimodal single-cell data. Cell, 2021, 184: 3573-3587.e29.

[54] HafemeisterC, SatijaR. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol., 2019, 20. 296

[55] TiroshI, et al.. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science, 2016, 352: 189-196.

[56] StuartT, et al.. Comprehensive integration of single-cell data. Cell, 2019, 177: 1888-1902.e21.

[57] WangX, et al.. Reinvestigation of classic T cell subsets and identification of novel cell subpopulations by single-cell RNA sequencing. J. Immunol., 2022, 208: 396-406.

[58] LeeNYS, LiM, AngKS, ChenJ. Establishing a human bone marrow single cell reference atlas to study ageing and diseases. Front. Immunol., 2023, 141127879.

[59] JinS, et al.. Inference and analysis of cell-cell communication using CellChat. Nat. Commun., 2021, 12. 1088

[60] KimH-N, et al.. Pathway analysis of genome-wide association datasets of personality traits. Genes Brain Behav, 2015, 14: 345-356.

[61] Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst 1, 417–425 (2015).

Funding

U.S. Department of Health & Human Services | National Institutes of Health (NIH)(GR00008150)

RIGHTS & PERMISSIONS

The Author(s)